Evidence map›Paper›PMID 26044589›Full record

ArticleEuropean journal of medical research2015

Fabrication of electrospun poly(D,L lactide-co-glycolide)80/20 scaffolds loaded with diclofenac sodium for tissue engineering.

Lila Nikkola, Tatjana Morton, Elizabeth R Balmayor, Hanna Jukola, Ali Harlin, Heinz Redl, Martijn van Griensven, Nureddin Ashammakhi

Open access · goldAbstract read
In one paragraph

Article in European journal of medical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Highlights on Advancing Frontiers in Tissue Engineering.Tissue engineering. Part B, Reviews · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Lila NikkolaDepartment of Biomedical Engineering, Tampere University of Technology, Tampere, Finland. lilanikkola@gmail.com.
Tatjana MortonAUVA Research Center, Austrian Cluster for Tissue Regeneration, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria. tm@crosstec.eu.
Elizabeth R BalmayorDepartment of Experimental Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Strasse 22, D-81675, Munich, Germany. Elizabeth.Rosado-Balmayor@tum.de.
Hanna JukolaDepartment of Biomedical Engineering, Tampere University of Technology, Tampere, Finland. Hanna.Jukola@tut.fi.
Ali HarlinInstitute of Fiber Material Science, Tampere University of Technology, Tampere, Finland. Ali.Harlin@tut.fi.
Heinz RedlAUVA Research Center, Austrian Cluster for Tissue Regeneration, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria. office@trauma.lbg.ac.at.
Martijn van GriensvenAUVA Research Center, Austrian Cluster for Tissue Regeneration, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria. vanGriensven@uchir.me.tum.de.
Nureddin AshammakhiDepartment of Biomedical Engineering, Tampere University of Technology, Tampere, Finland. nureddin.ashammakhi@tut.fi.
Tampere University · FIAustrian Cluster for Tissue Regeneration · ATKlinikum rechts der Isar · DELudwig Boltzmann Institute for Experimental and Clinical Traumatology · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdaptation of nanotechnology into materials science has also advanced tissue engineering research. Tissues are basically composed of nanoscale structures hence making nanofibrous materials closely resemble natural fibers. Adding a drug release function to such material may further advance their use in tissue repair.

methodsIn the current study, bioabsorbable poly(D,L lactide-co-glycolide)80/20 (PDLGA80/20) was dissolved in a mixture of acetone/dimethylformamide. Twenty percent of diclofenac sodium was added to the solution. Nanofibers were manufactured using electrospinning. The morphology of the obtained scaffolds was analyzed by scanning electron microscopy (SEM). The release of the diclofenac sodium was assessed by UV/Vis spectroscopy. Mouse fibroblasts (MC3T3) were seeded on the scaffolds, and the cell attachment was evaluated with fluorescent microscopy.

resultsThe thickness of electrospun nanomats was about 1 mm. SEM analysis showed that polymeric nanofibers containing drug particles formed very interconnected porous nanostructures. The average diameter of the nanofibers was 500 nm. Drug release was measured by means of UV/Vis spectroscopy. After a high start peak, the release rate decreased considerably during 11 days and lasted about 60 days. During the evaluation of the release kinetics, a material degradation process was observed. MC3T3 cells attached to the diclofenac sodium-loaded scaffold.

conclusionsThe nanofibrous porous structure made of PDLGA polymer loaded with diclofenac sodium is feasible to develop, and it may help to improve biomaterial properties for controlled tissue repair and regeneration.

Indexed as

3T3 CellsAnimalsDiclofenacDrug LiberationFibroblastsMiceNanofibersPolyglactin 910Tissue EngineeringTissue ScaffoldsDiclofenacPolyglactin 910

Identifiers

PMID26044589
PMCPMC4465314
OpenAlexW1856673974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.